Maverick recently received an audit by Australian Quarantine Inspection Services (AQIS) personnel with regard to attaining listing as an exporter of “intermediate Products” to the EU. Listing is expected within the month, therefore easing constraints on exporting of processed biological […]

Maverick Biomaterials Pty Ltd, producer of cross linked GBR1 bovine pericardium in Australia and New Zealand, was audited on 23rd November by BSi for ISO 13485 Certification. This certification will optimise Maverick Biomaterials production and export of cross linked GBR1 […]

Maverick Biomaterials is making solid progress towards probable attainment of ISO 13485 certification for Q1 2012. A Notify body audit will be completed late in the year with Mavericks Quality Manager quietly confident of a successful outcome. This will be […]

Maverick Biomaterials is continuing to advance its IP portfolio with regard to 3 Dimensional (3D) fixation of specifically sourced raw pericardium from it supplier Maverick Biosciences. Recent production for a range of global clients has been well received, with Maverick Biomaterials […]

13th January 2011, Maverick Biosciences Limited and Maverick Biosciences (NZ) Limited today received a surveillance audit by Det Norske Veritas. There were no ‘Non Conformities’ found in either minor or major categories, 1 observation was noted. The Quality Management system […]

11th January 2010. Maverick Biosciences Pty Limited and Maverick Biosciences (NZ) Limited was today awarded ISO.9001:2008 certification by Det Norske Veritas, valid until 2013. It has been a very pleasing outcome in that our investment in a Quality Management infrastructure […]

In June 2009 Maverick commenced a 3 month trial production of pericardium against very tightly defined specifications, targeting achievement of a significant increase in the overall yields experienced by our manufacturing client. Mavericks remote production team has been completely trained […]

Maverick has been working with a number of start-up clients to resolve their need for “backroom” processing activities to be undertaken as an outsourced function so as to reduce their infrastructural investment and provide them more time and focus on […]

After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease […]

Maverick has this week, drafted a project plan for the production and selection of sized porcine leaflets, for fixation in Australia, prior to export. Expanding upon its success in the bovine and equine tissues area, Maverick has built a project […]